Although relatively rare, cardiomyopathy (CM) is among the leading important causes of morbidity and mortality in infants and children. Children with CM are commonly classified into four large functional groups: Dilated, Hypertrophic, and Restrictive, Arrhythmogenic Right Ventricular cardiomyopathy. The majority of cases are dilated cardiomyopathy (DCM). A substantial proportion die and these children make up the largest group of heart transplant recipients among children with CM. Therefore, they serve as an ideal group to identify predictors of outcomes, which include death and heart transplant. Predictors of outcomes have been described in various single institution studies, with many factors have been proposed including older age and decreased fractional shortening, among others, but none have been uniformly present in all studies. Only a few studies have employed multivariate Cox regression models. This study will capitalize on the pre-existing, robust dataset from the Pediatric Cardiomyopathy Registry (PCMR), which contains baseline clinical and demographic information, as well as extensive longitudinal follow-up. Supported by the NIH-NHLBI since 1995, the PCMR has enabled the pooling of data collected by centers across the US and Canada and permitted previously impossible analyses. Although prior PCMR analysis has included etiology of DCM in their model of prognostic factors, etiology-specific analyses based on baseline data, simulating real-time clinical practice, have yet to be performed. Semiparametric Kaplan- Meier and Cox Proportional Hazard methods for survival data analysis are commonly applied for independent outcomes, however, when multiple events of interest with possible dependence are under consideration, the parametric competing risk method of analysis may be more appropriate. In light of the challenges and gaps in knowledge presented, the following specific aims are proposed:
AIM 1 : Describe demographic and clinical factors measured at time of diagnosis.
AIM 2 : Identify factors measured at time of diagnosis which are prognostic of poor outcomes (death or trans- plant) utilizing the Cox proportional hazards regression method.
AIM 3 : Identify factors measured at time of diagnosis which are prognostic of poor outcomes (death or trans- plant) utilizing the competing risks method. Results of this study will greatly enhance the clinician's ability to interpret the risk of death, trans-plant, or long-term survival for a child with DCM. In turn, this will assist with the timely, efficient use of resources to improve the outcomes and quality of life for the child with this disease, his or her family, and society. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31HL094100-01
Application #
7546725
Study Section
Special Emphasis Panel (ZRG1-HOP-Z (29))
Program Officer
Meadows, Tawanna
Project Start
2008-08-19
Project End
2011-08-18
Budget Start
2008-08-19
Budget End
2009-08-18
Support Year
1
Fiscal Year
2008
Total Cost
$27,469
Indirect Cost
Name
University of Miami School of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Bansal, Neha; Barach, Paul; Amdani, Shahnawaz M et al. (2018) When is early septal myectomy in children with hypertrophic cardiomyopathy justified? Transl Pediatr 7:362-366
Lipshultz, Steven E (2018) Letter by Lipshultz Regarding Article, ""Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?"" Circ Res 122:e62-e63
Hutchins, Kelley K; Siddeek, Hani; Franco, Vivian I et al. (2017) Prevention of cardiotoxicity among survivors of childhood cancer. Br J Clin Pharmacol 83:455-465
Lipshultz, Steven E; Anderson, Lynn M; Miller, Tracie L et al. (2016) Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors. Cancer 122:946-53
Franco, Vivian I; Lipshultz, Steven E (2015) Cardiac complications in childhood cancer survivors treated with anthracyclines. Cardiol Young 25 Suppl 2:107-16
Lipshultz, Steven E; Franco, Vivian I; Miller, Tracie L et al. (2015) Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med 66:161-76
Lipshultz, Steven E; Chandar, Jayanthi J; Rusconi, Paolo G et al. (2014) Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) 69 Suppl 1:55-72
Lipshultz, Steven E; Lipsitz, Stuart R; Kutok, Jeffery L et al. (2013) Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia. Cancer 119:3555-62
Landy, David C; Lipsitz, Stuart R; Kurtz, Joy M et al. (2013) Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: an analysis from the cardiac risk factors in childhood cancer survivors study. Nutr Cancer 65:547-55
Landy, David C; Miller, Tracie L; Lipsitz, Stuart R et al. (2013) Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study. Pediatr Cardiol 34:826-34

Showing the most recent 10 out of 20 publications